When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant files U.S. application for relugolix for prostate cancer
Myovant Sciences Ltd.
Myovant Sciences (NYSE:MYOV) has submitted a marketing application to the FDA seeking approval to use oral relugolix (120 mg) to treat men with advanced prostate cancer.
More news on: Myovant Sciences Ltd., Healthcare stocks news, Stocks on the move,